ANALIS
ActiveFrom the official registers: KBO 54 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
ANALIS has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15.1m and a net result of €1.1m. Equity has been growing by about 8.6% per year since 2018. Its solvency ranks better than 50% of 144 sector peers (NACE 32, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 30-03-1987 Normal situation
- Legal form
- Public limited company
- Registered office
- Rue de Néverlée(RH) 11, 5020 Namur
- Activity
- Manufacture of medical and dental instruments and supplies NACE 32500and 3 others
- Establishment units
- 2.032.563.932 5020 Namur, since 09-04-1987
- 2.142.912.716 9051 Gent, since 09-04-1987
- Financial year end
- 31 December
- Peppol
- Reachable since 10-03-2026
Board and ownership
- COUNE OLIVIERDirector · since 28-05-2021
- Brigitte LacosteDirector · since 03-06-2022
- Dorian LacosteDirector · since 26-05-2023
- Ladislas HermanDirector · since 26-05-2023
- Holdings
- Shares in 5 companies including ANALIS BV and LABOTECH
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Turnover
- €46.1m
- ▲ 9.7%
- Profit
- €1.1m
- ▼ 15.3%
- Equity
- €15.1m
- ▲ 1.7%
- Total assets
- €31.0m
- ▲ 4.2%
- Staff
- 128 FTE
- ▼ 7.2%
Score breakdownraises riskLiquidity: current ratio 1.92, cash €1.7mlowers riskFounded in 1987Size: turnover €46.1m, 128 FTE, total assets €31.0m, files consolidated accountsLegal form: public limited companyShow the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (all companies). It does better than 65% of them on solvency, 39% on liquidity, 56% on profitability and 63% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
The company filed its last 5 accounts on average 35 days before the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Largest company by total assets in the province of Namur, Other manufacturing…in the Checked rankings No. 1 View
- Positive: 8 profitable years in a rowprofit 2025: €1.1m 8 years View
- Merger with ANALIS DEVELOPMENTmerger on 31-12-2024 2024 View
- Heads a groupcompanies controlled 4 View
- Positive: Always filed on timeaccounts within the deadline every year 5 years View
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 16-06-2026
- Consolidated accounts 2025filed on 19-06-2026
- Annual accounts 2024filed on 27-06-2025
- Consolidated accounts 2024filed on 01-07-2025
Acts in the Belgian Official Gazette
- Restructuringact of 03-07-2025
- Resignations & appointmentsact of 26-06-2025
- Restructuring · Miscellaneousact of 06-02-2025
- Resignations & appointmentsact of 30-06-2023
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about ANALIS
- What is the company number of ANALIS?
- The company number of ANALIS is 0430.744.435. The VAT number is the same number with BE in front: BE 0430.744.435.
- Where is ANALIS based?
- The registered office is at Rue de Néverlée(RH) 11, 5020 Namur.Company details
- What does ANALIS do?
- According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
- What is the legal form of ANALIS?
- The legal form of ANALIS is Public limited company (NV).
- When was ANALIS founded?
- ANALIS was founded on 30-03-1987.
- Is ANALIS still active?
- Yes, ANALIS is an active enterprise in the KBO register.
- How many employees does ANALIS have?
- ANALIS had an average of 128 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of ANALIS?
- The turnover of ANALIS was €46.1m in financial year 2025, according to the filed annual accounts.
- Is ANALIS profitable?
- In financial year 2025, ANALIS made a profit of €1.1m.
- Where can I find the annual accounts of ANALIS?
- ANALIS filed 54 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of ANALIS due?
- ANALIS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Companies linked to ANALIS
Comparable companies
These companies have the same main activity as ANALIS: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €8.5m and €63m, founded between 1970 and 2004.
| Company | Total assets | Turnover |
|---|---|---|
| ANALIS Namur | €31.0m | €46.1m |
| Eqwal Gent | €21.6m | €38.9m |
| ORFIT INDUSTRIES Wijnegem | €24.9m | €31.0m |
| Disposable Medical Equipment Frameries | €16.1m | €18.4m |
| MOLNLYCKE HEALTH CARE Waremme | €42.1m | €123.2m |
| DENTAL PROMOTION & INNOVATION Anderlecht | €63.0m | €116.8m |
| BELGIAN DIAGNOSTIC COMPANY Marche-en-Famenne | €8.5m | €17.7m |
Next steps
See how customers, suppliers and banks see your own company and what to improve first.